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In response to viral infection, the expression of numerous host genes, including predominantly a number of proinflammatory
cytokines and chemokines, is usually up-regulated at both transcriptional and translational levels. It was noted that in cells
infected with coronavirus, transcription and translation of some of these genes were differentially induced. Drastic induction
of their expression at the transcriptional level was observed in cells infected with coronavirus. However, induction of the same
genes at the translational level was usually found to be minimal to moderate. To investigate the underlying mechanisms, yeast
two-hybrid screen was carried out using SARS-CoV proteins as baits, revealing that a subunit of the eukaryotic initiation factor
3 (eIF3), eIF3f, may interact with the N-terminal region of the SARS-CoV spike (S) protein. This interaction was subsequently
confirmed by co-immunoprecipitation and immunofluorescent staining. Meanwhile, parallel experiments confirmed that eIF3f
could also interact with the S protein of another coronavirus, the avian coronavirus infectious bronchitis virus (IBV). These
interactions led to the inhibition of translation of a reporter gene in both in vitro expression system and intact cells.
Interestingly, IBV-infected cells stably expressing a Flag-tagged eIF3f showed much higher translation of IL-6 and IL-8,
suggesting that the interaction between coronavirus S protein and eIF3f plays a functional role in controlling the expression of
host genes, especially genes that are induced during coronavirus infection cycles. This study reveals a novel mechanism
exploited by coronavirus to regulate viral pathogenesis.
Citation: Xiao H, Xu LH, Yamada Y, Liu DX (2008) Coronavirus Spike Protein Inhibits Host Cell Translation by Interaction with eIF3f. PLoS ONE 3(1):
e1494. doi:10.1371/journal.pone.0001494
INTRODUCTION
Activation and induction of host gene expression at both
transcriptional and translational levels by virus infection constitute
essential steps in host anti-viral response and viral pathogenesis. As
one of the major factors that causes tissue damage and viral
pathogenesis, induction and over-production of proinflammatory
cytokines and chemokines are a common phenomenon in many
viral infections [1–6]. However, it was frequently observed that the
expression of these genes was differentially up-regulated at the
transcriptional and translational levels in cells infected with a
certain virus. For example, in cells infected with severe acute
respiratory syndrome coronavirus (SARS-CoV) and in sera from
SARS patients, significant up-regulation of the transcription of
proinflammatory cytokines and chemokines, such as CCL1,
CCL2, CCL3, CCL5, CCL9, CXCL10, IL-6, IL10 and IL12,
was reported [5,7–10]. However, only a moderate increase of the
expression of these genes at the protein level was detected [8–9].
This differential up-regulation of the host gene expression at
transcriptional and translational levels may simply reflect the
relative capacity of host transcription and translation machinery in
the infected cells. Alternatively, it would consist of a convenient
and clever viral strategy to counteract host cell anti-viral response,
as over-production of these host proteins is usually harmful to
viruses. In this study, we show a novel mechanism exploited by
coronavirus to regulate the translation of virus-induced genes at
late stages of the virus infection cycle.
Coronavirus is an important pathogen of human and animals. It
is the etiological agent of SARS [11–12]. Coronavirus is an
enveloped virus with a single strand, positive-sense RNA genome
of 27–32 kb in length. In coronavirus-infected cells, a 39-
coterminal nested set of six to nine mRNA species, including the
genome-length mRNA (mRNA1) and five to eight subgenomic
mRNA species (mRNA2-9), is expressed. The genome-length
mRNA1 encodes two overlapping replicase proteins in the form of
polyproteins 1a and 1a/b, which are processed by virus-encoded
proteinases into at least 16 putative nonstructural proteins (NSP1-
NSP16) [13–15]. The four major structural proteins, spike (S),
envelope (E), membrane (M) and nucleocapsid (N), are encoded by
different subgenomic mRNAs. In addition, several accessory
proteins are also encoded by subgenomic mRNAs [15]. In
coronavirus-infected cells, no obvious inhibition of host protein
synthesis was observed at least at early stages of the virus infection
cycle.
Viruses rely on the canonical cellular translation machinery to
translate their own RNAs. This would facilitate the rapid
production of viral proteins and meanwhile, render inhibitory
effect on the production of host proteins including host anti-viral
proteins [16]. In fact, viruses may inhibit host protein synthesis by
targeting multiple steps in the gene expression process via various
vices. For instance, vesicular stomatitis virus M protein inhibits the
initiation of transcription of host genes [17–20], while adenovirus
encodes VA RNA, a small highly structured RNA that
competitively binds to the dsRNA-binding site of the double-
strand RNA activated kinase (PKR) and prevents its activation
[21]. The majority of control over cellular mRNA translation,
however, occurs at the initiation stage, the rate-limiting step of
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initiation begins with binding of the initiator Met-tRNAi to the
40S ribosomal subunit. This is facilitated by the formation of a
eukaryotic initiation factor 2 (eIF2)/GTP/Met-tRNAi ternary
complex and a subsequent 43S preinitiation complex. Viruses
could inhibit cellular protein synthesis by targeting and inactivat-
ing components of the initiation complex. One well studied
example is the picornaviral 2A proteinase which cleaves the
initiation factor eIF4G within its N-terminal region containing the
binding site for eIF4E and poly(A)-binding protein (PABP) [24–
27]. The cleaved C-terminal region of eIF4G could be associated
with eIF3 and eFI4A, binds with higher affinity to viral mRNAs
and facilitates translation of its own protein [26,28].
The initiation factor eIF3 plays an important role during
translation initiation by bridging the 43S preinitiation complex to
mRNA via the cap binding complex eIF4F. Assembled into a large
multi-subunit protein complex of approximately 650 kDa, eIF3
consists of at least 10 subunits, p170, p166, p110, p66, p48 (int6),
p47 (eIF3f), p44, p40, p36 and p35 [29–31]. We show here that
eIF3f could interact with the S protein from two coronaviruses,
SARS-CoV and the coronavirus infectious bronchitis virus (IBV).
These interactions led to the inhibition of translation. Interestingly,
IBV-infected cells stably expressing a Flag-tagged eIF3f showed
much higher translation of IL-6 and IL-8. This study reveals a
novel mechanism exploited by coronavirus to counteract host-
antiviral response and, meanwhile, regulate the pathogenesis of
coronavirus.
MATERIALS AND METHODS
Cells and Cell Culture
Cells were cultured in complete Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 5% newborn calf serum
(Sterile) and 1% penicillin/streptomycin (Invitrogen), and main-
tained at 37uC in humidified 5% CO2.
Yeast two-hybrid Screening
The N-terminal region from amino acids 20 to 404 (SDC) of the
SARS-CoV S protein was used as bait to screen a cDNA library
prepared from HeLa cells (BD Biosciences Clontech), as previously
described [32]. Plasmid pGBKT7 contains an ADH1 promoter
which directs high level expression of fusion protein in yeast; it also
contains a T7 promoter and a c-Myc epitope tag. Briefly, the bait
construct pGBKT7-SDC was first transformed into the yeast strain
AH109 using lithium acetate method described in the Clontech
manual, and 100 mg of cDNA library DNA was sequentially
transformedintothepGBKT7-SDC-transformants. Thetransformed
cells were plated on minimal selective synthetic dropout (SD) media
SD/-Leu/-Trp/-His plate and positive colonies were selected by
dotting colonies onto SD/-Leu/-Trp/-His/-X-a-gal plates. Potential
positive gene was determined by direct PCR of individual yeast
colonies followed by automated nucleotide sequencing.
Co-immunoprecipitation and Western blot
Exponentially growing cells were seeded at ,2610
6 in 6 well
plates and transfected with appropriate plasmids. At 24 hours
post-transfection, the cells were washed with ice-cold PBS twice
and lysed with 250 ml of ice-cold cell lysis buffer (140 mM NaCl,
10 mM Tris-HCl pH 8.0 and 5 mM NP-40). The total cell lysates
were clarified by centrifugation at 13,000 rpm for 10 minutes, and
the first antibody was added to the supernatants. After incubation
at room temperature for 45 minutes, protein A-Sepharose beads
were added, and incubation was continued for an additional
30 min. The precipitates were collected by centrifugation and the
beads were washed 5 times with the lysis buffer before subjected to
SDS-PAGE. In some cases, M2 anti-Flag Sepharose beads
(Sigma), instead of the primary antibodies and protein A-
Sepharose beads, were used.
Purification of recombinant protein from E. coli
Plasmids pGEX-5X1, pGEX-SDC and pGEX-3f were expressed
in bacteria by induction with 0.4 mM IPTG at 37uC for 3 hours.
GST and GST fusion protein were purified using the GST
purification module (Amersham).
Sucrose density gradient centrifugation
15%–50% linear sucrose gradients in PBS with protease inhibitor
cocktail (Roche) were prepared using a Hoefer SG15 gradient
maker. The gradients were allowed to stand for 3 to 5 hours at
4uC before layering a 0.2-ml sample onto a gradient. The GST-3f
and GST-SDC proteins were purified using the GST purification
module (Amersham), and 10 mg of each protein were loaded onto
the top of the gradient and centrifuged in a Beckman LZ-65
ultracentrifuge using an SW60 rotor at 40,000 g for 20 hours.
After centrifugation, 14 fractions were collected from the top to the
bottom of the gradient and analyzed by Western blot.
In vitro transcription and translation inhibition
assay
In vitro transcription of luciferase RNA was preformed using T7
RNA polymerase (Promega). After extraction with phenol/
chloroform, the in vitro transcribed RNA was precipitated with
ethanol and dissolved in RNase-free water.
In vitro translation was performed in rabbit reticulocyte lysates
in the presence of [
35S] methionine based on the protocol
recommended by the manufacturer (Promega). The in vitro
transcribed Luc mRNA was added to a master tube containing the
in vitro translation reaction mixture. The mixture was then
aliquoted and increasing amounts of purified GST and GST-SDC
proteins were added to each tube as indicated. Translation was
allowed to proceed at 30uC for 90 min. After incubation, a 5 ml
aliquot of the reaction was resolved by SDS-10% polyacrylamide
gel and the polypeptides were detected by autoradiography.
Transient expression of viral protein in mammalian
cells
Viral or cellular genes cloned into plasmids under the control of a
T7 promoter were transiently expressed in mammalian cells using
a vaccinia virus/T7 system, as previously described [33]. Briefly,
semiconfluent monolayers of HeLa cells were infected with a
recombinant vaccinia virus (vTF7-3), which expresses the T7 RNA
polymerase gene, for 2 hours at 37uC prior to transfection. The
plasmid DNA was transfected into vTF7-3-infected cells using
Effectene transfection reagent (QIAGEN) according to the
manufacturer’s instructions.
Inhibition assay in intact cells
HeLa cells on 6-well plates were infected with the recombinant
vaccinia virus vTF7-3, and transfected with 1.2 mg of empty vector
pKT0, 1 mg pKT0/S+0.2 mg pLUC, and 1 mg pKT0+0.2 mg
pLUC, respectively, using the effectene transfection kit (QIA-
GEN). At 24 hours post-transfection, cells were lysed using the
passive cell lysis buffer provided by Promega and luciferase activity
was measured using the Dual-Luciferase Reporter Assay System
(Promega).
Coronavirus S and eIF3f
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HeLa cells, grown on 24 well plates, were infected with vTF7-3
and transfected with appropriate plasmid DNA. After washing
with PBS, the cells were fixed with 4% paraformaldehyde for
30 minutes at room temperature and permeabilized with 0.2%
Triton X-100, followed by incubation with specific antiserum at
room temperature for 2 hours. The cells were then washed with
PBS and incubated with fluorescein isothiocyanate- or tetra-
methylrhodamine isothiocyanate-conjugated anti-rabbit or anti-
mouse IgG (Sigma) in fluorescence dilution buffer at 4uC for
2 hours before mounting.
Construction of plasmids
Plasmid pGBKT7-SDC( d e n o t e da sS DC), which covers the N-
terminal region (20-404aa) of the SARS-CoV S protein, was
constructed by cloning an EcoRI/BamHI digested PCR fragment
into EcoRI/BamHI digested pGBKT7 (Clontech). The PCR
fragment was generated with full-length SARS-CoV S gene using
primers (59-CGGAATTCCTTGACCGGTGCACC ACTT-39)
and (59-CGGGATCCCTGGCGCTATTTGTCTTACATC-39).
Plasmid pIBV-SDC, which covers the equivalent region to the
SDC of SARS-CoV, was PCR amplified using specific primers pairs
andclonedinto pGBKT7.PlasmidpFlag-3fwascreatedbycloning a
SmaI/HindIII digested pGAD-3f fragment into EcoRV/HindIII
digested pFlag. Plasmid pGEX-SDC was created by cloning a
EcoRI/SalI digested pGBKT7-SDC into EcoRI/XhoI digested
pGEX-5X1.Plasmid pGEX-3fwasconstructedbycloningaEcoRI/
XhoI digested pGAD-3f into EcoRI/XhoI digested pGEX-5X3. All
constructs were confirmed by automated nucleotide sequencing.
RESULTS
Interaction of SARS-CoV S protein with eIF3f
Virus infection activates transcription and translation of many host
genes. During the course of studying the gene expression profiles
in cells infected with coronaviruses, it was noted that drastic
induction of many virus-inducible genes occurred at the
transcriptional level. However, induction of the same genes at
the translational level was found to be usually minimal to
moderate. To search for cellular proteins that are involved in
protein synthesis and may interact with coronavirus proteins, yeast
two-hybrid screening was carried out using different coronavirus
proteins as baits. This screening led to the identification of eIF3f
that could potentially interact with the N-terminal portion (SDC)
of the SARS-CoV S protein. Co-immunoprecipitation experi-
ments were performed to further test the interaction between SDC
and eIF3f. To facilitate detection of the two proteins, SDC was
tagged with a Myc tag and eIF3f with a Flag tag at the N-termini,
respectively. Analysis of HeLa cells expressing the Myc-tagged
SDC either on its own or together with the Flag-tagged eIF3f by
Western blot with anti-Myc monoclonal antibody led to efficient
detection of the Myc-tagged SDC (Fig. 1a, top panel, lanes 1 and
3). Similarly, analysis of cells expressing the Flag-tagged eIF3f
either on its own or together with the Myc-tagged SDCb y
Western blot with anti-Flag monoclonal antibody showed presence
of the Flag-tagged eIF3f (Fig. 1a, second panel, lanes 2 and 3). The
same cell lysates were then subjected to immunoprecipitation with
anti-Flag antibody. Western blot analysis of the precipitates with
anti-Flag antibody detected the Flag-tagged eIF3f expressed either
on its own or together with the Myc-tagged SDC (Fig. 1a, third
panel, lanes 2 and 3). Western blot analysis of the same
precipitates with anti-Myc antibody showed presence of the
Myc-tagged SDC only in cells co-expressing the two proteins
(Fig. 1a, bottom panel, lane 3). These results confirm that the N-
terminal portion of the SARS-CoV S protein can indeed interact
with eIF3f.
Similar experiments were then performed to check if the full-
length SARS-CoV S protein could also interact with eIF3f. As
shown in Fig. 1b, efficient detection of the full-length S protein was
obtained in cells expressing S protein either on its own or together
with the Flag-tagged eIF3f by Western blot with anti-S polyclonal
antibodies (Fig. 1b, top panel, lanes 1 and 3). Analysis of cells
expressing the Flag-tagged eIF3f either on its own or together with
S protein by Western blot with anti-Flag monoclonal antibody
showed presence of the Flag-tagged eIF3f (Fig. 1b, second panel,
lanes 2 and 3). Immunoprecipitation of the cell lysates with anti-S
antibodies and subsequent analysis of the precipitates by Western
blot with anti-S antibodies detected the S protein in cells expressing
the protein either on its own or together with the Flag-tagged eIF3f
(Fig. 1b, third panel, lanes 1 and 3). Western blot analysis of the
same precipitates with anti-Flag antibody showed presence of the
Flag-tagged eIF3f only in cells co-expressing the two proteins
(Fig. 1b, bottom panel, lane 3). These results confirm that the full-
length S protein can also interact with eIF3f.
This interaction was further investigated in cells co-expressing
the two proteins by immunofluorescent staining. In HeLa cells
expressing the Flag-tagged eIF3f alone, the protein was located in
both the cytoplasm and the nucleus with predominant nuclear
localization in some cells (Fig. 1c, panel A). In cells expressing the
S protein alone, the protein is exclusively detected in the cytoplasm
(Fig. 1c, panel B). In cells co-expressing the two proteins, the Flag-
tagged eIF3f was found to exhibit a subcellular localization pattern
similar to the S protein (Fig. 1c, panels C–E). The staining patterns
of the two proteins are well overlapped (Fig. 1c, panel E),
suggesting that the S protein may sequester the eIF3f to the
cytoplasm.
In vitro formation of complexes between GST-SDC
and GST-eIF3f
The interaction between SARS-CoV S protein and eIF3f was
further investigated by checking if the two proteins could form
complexes in vitro. The SDC and eIF3f were expressed in E. coli as
GST fusion proteins and purified to near homogeneity (data not
shown). The purified proteins GST-SDCe i t h e ro ni t so w no rm i x e d
with an equal amount of GST-eIF3f was subjected to ultracentri-
fugation through 15–50% sucrose gradients, and 14 fractions were
collected. As shown in Fig. 2, GST-SDCo ni t so w nw a se x c l u s i v e l y
detected in fraction 5 (top panel). When GST-eIF3f was mixed with
the purified GST alone, it was mainly detected in fractions 4–6
(Fig. 2, second panel). When GST-eIF3f was mixed with GST-SDC,
both proteins were detected in fractions 11–14 (Fig. 2, third and
bottom panels). These results substantiate the conclusion that SDC
could interact with eIF3f and further demonstrate that the two
proteins could form stable complexes in vitro.
Inhibition of the translation of a reporter gene by
SARS-CoV S protein
We next set up to study the functional consequence of the
confirmed interaction between SARS-CoV S protein and eIF3f in
vitro. Equal amounts of the in vitro transcribed mRNA derived
from the luciferase gene were translated in the presence of
increasing amounts of purified GST-SDC protein. As shown in
Fig. 3a, progressive inhibition of the luciferase gene expression was
observed when 30 to 600 nM of GST-SDC protein was added to
the system (lanes 2–8). Complete inhibition of the luciferase
expression was achieved when 600 nM of the purified GST-SDC
protein was used (Fig. 3a, lane 8). In contrast, much less inhibitory
Coronavirus S and eIF3f
PLoS ONE | www.plosone.org 3 January 2008 | Issue 1 | e1494Figure 1. Confirmation of the interaction between SARS-CoV S protein and eIF3f by co-immunoprecipitation and immunofluorescence. a.
Interaction of eIF3f with the N-terminal portion of SARS-CoV S protein (SDC). HeLa cells expressing the Myc-tagged SDC (lane 1), the Flag-tagged
eIF3f (lane 2) and eIF3f+SDC (lane 3) were harvested at 24 hours post-transfection and lysed. The total lysates were either detected directly by
Western blot with anti-Myc (top panel) and anti-Flag (second panel) antibodies, respectively, or immunoprecipitated with anti-Flag antibody. The
precipitates were analyzed by Western blot with anti-Flag (third panel) and anti-Myc (bottom panel) antibodies. b. Interaction of eIF3f with the full-
length SARS-CoV S protein. HeLa cells expressing the SARS-CoV S (lane 1), the Flag-tagged eIF3f (lane 2) and eIF3f+S (lane 3), were lysed. The total
lysates were either detected directly by Western blot with anti-S (top panel) and anti-Flag (second panel) antibodies, respectively, or
immunoprecipitated with anti-S antibodies. The precipitates were analyzed by Western blot with anti-S (third panel) and anti-Flag (bottom panel)
antibodies. c. Subcellular localization of eIF3f and SARS-CoV S protein by immunofluorescent staining of HeLa cells expressing eIF3f (panel A), SARS-
CoV S protein (panel B) or co-expressing eIF3f and S (panels C, D and E). The subcellular localization of the proteins were examined at 12 hours post-
transfection by dual labelling with a mixture of anti-S (rabbit) and anti-Flag (mouse) antibodies, followed by incubating with a mixture of FITC-
conjugated anti-mouse and tetramethyl rhodamine isocyanate-conjugated anti-rabbit antisera. Panel C shows the staining profile of eIF3f, panel D
shows the staining pattern of SARS-CoV S protein, and panels E shows the overlapping images C and D.
doi:10.1371/journal.pone.0001494.g001
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used (Fig. 3a, lanes 9 and 10).
As 600 nM of GST-SDC was shown to completely inhibit the
expression of luciferase, addition of equal amount of the purified
GST-eIF3f to the in vitro translation system was carried out to see
if the inhibitory effect can be reversed. As anticipated, addition of
exogenous GST-eIF3f fusion protein substantially relieved the
inhibitory effect (Fig.3a, lane 14). However, addition of the same
amount of the purified GST did not rescue the expression of the
reporter gene (Fig. 3a, lane 13).
To further test if similar inhibition of the reporter gene translation
could be observed in intact cells, luciferase gene under the control of
a minimal promoter was co-transfected into HeLa cells either with
an empty control plasmid (pKT0) or the full-length S protein. At
24 hours post transfection, cells were lysed and aliquoted. A portion
of the lysates was used for luciferase assay while another was used for
Western blot analysis of the protein expression. Expression of S
protein could substantially inhibit the luciferase expression (Fig.3b,
lane 2), whereas the empty vector alone did not cause any inhibition
(Fig. 3b, lane 3). Quantitative analysis of the inhibitory effect by
measuring the luciferase activity showed that in cells transfected with
Luc+empty vector, the relative luciferase activity is 1936 light units,
which are 37-fold higher than that in cells transfected with Luc+S.
Northern blot analysis confirmed that approximately equal amounts
of luciferase mRNA were detected in cells transfected with luciferase
togethereitherwith anemptyvectororthe Sconstruct(Fig.3b,lanes
4 and 5).
Interaction of IBV S protein with eIF3f and inhibition
of the translation of a reporter gene
Co-immunoprecipitation was performed to check if IBV S protein
could also interact with eIF3f. Detection of the full-length IBV S
protein was obtained in cells expressing S protein either on its own or
Figure 2. Co-fractionation of SDC with eIF3f in vitro in sucrose
gradients.Ten micrograms eachofthepurifiedGST-SDC (toppanel), GST-
3f+GST (second panel) and GST3f+GST-SDC (third and bottom panels)
wereloaded ontothe topof15–50%sucrose gradients andcentrifugedat
40,000 g for 20 hours. Fourteen fractions were collected from the top to
the bottom and analyzed by Western blot with anti-S (top and bottom
panels) and anti-eIF3f (second and third panels) antibodies.
doi:10.1371/journal.pone.0001494.g002
Figure 3. Inhibition of protein synthesis by interaction of SARS-CoV S protein with eIF3f. a. Dose dependent inhibition of luciferase mRNA
translation by GST-SDC in vitro (lanes 1–10) and rescue of the inhibition by addition of the purified GST-3f (lanes 11–14). In vitro transcribed luciferase
mRNA (0.5 mg) was translated in vitro in rabbit reticulocyte lysates in the presence of [
35S] methionine. Glutathione buffer (lane 1), increasing amounts
of GST-SDC (lanes 2–8), GST (lanes 9–10), purified GST (lane 11), GST-SDC (lane 12), GST+GST-SDC (lane 13), or GST-SDC+GST-3f (lane 14) were added
to the translation system as indicated. Polypeptides were separated on SDS-10% polyacrylamide gel and visualized by autoradiography (upper
panels). A duplicate of the in vitro translation reactions in the absence of [
35S] methionine (replaced by cold-methionine) was used to measure the
luciferase activity (lower graph). b. Inhibition of luciferase translation by the full-length SARS-CoV S protein in intact cells. HeLa cells on 6-well plates
were infected in duplicate with the recombinant vaccinia virus vTF7-3, and transfected with 1.2 mg of empty vector pKT0 (V) (lanes 1 and 6), 1 mg
pKT0/S+0.2 mg pLUC (lanes 2 and 5), and 1 mg pKT0+0.2 mg pLUC (lanes 3 and 4), respectively. Cells were harvested at 24 hours post-transfection,
and protein expression was analyzed by Western blot with anti-luciferase and anti-S antibodies. The same membrane was also probed with anti-actin
antibodies as a loading control. The luciferase gene expression at the mRNA level in the transfected cells was also analyzed by Northern blot with a
Dig-labeled DNA probe corresponding to the 59-end 550 nucleotides of the luciferase gene (lanes 4–7).
doi:10.1371/journal.pone.0001494.g003
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anti-IBV S polyclonal antibodies (Fig. 4a, second panel, lanes 2 and
3). Analysis of cells expressing the Flag-tagged eIF3f either on its own
or together with S protein by Western blot with anti-Flag monoclonal
antibody showed presence of the Flag-tagged eIF3f (Fig. 4a, top
panel, lanes 1 and 3). Immunoprecipitation of the cell lysates with
anti-IBV S antibodies and subsequent analysis of precipitates by
Western blot with anti-IBV S antibodies detected the S protein in
cellsexpressing the proteineitheronitsownortogetherwith the Flag-
tagged eIF3f(Fig. 4a, third panel, lanes2 and 3). Westernblot analysis
of the same precipitates with anti-Flag antibody led to the detection of
the Flag-tagged eIF3f only in cells co-expressing the two proteins
(Fig. 4a, bottom panel, lane 3). These results confirm that the full-
length IBV S protein could also interact with eIF3f.
Co-immunoprecipitation experiments were then performed to
check if the N-terminal region of IBV S protein equivalent to the
SDC of SARS-CoV S protein could interact with eIF3f. Similarly,
the IBV SDC was tagged with the Myc tag and eIF3f with the Flag
tag at the N-termini, respectively. Analysis of cells expressing the
Myc-tagged IBV SDC either on its own or together with the Flag-
tagged eIF3f by Western blot with anti-Myc monoclonal antibody
showed presence of the Myc-tagged SDC (Fig. 4b, second panel,
lanes 2 and 3). Similarly, analysis of cells expressing the Flag-
tagged eIF3f either on its own or together with the Myc-tagged
IBV SDC by Western blot with anti-Flag monoclonal antibody
detected the Flag-tagged eIF3f(Fig. 4b, top panel, lanes 1 and 3).
Immunoprecipitation of the same cell lysates with anti-Flag
antibody and subsequent analysis of the precipitates by Western
blot with anti-Flag antibody led to the detection of the Flag-tagged
eIF3f expressed either on its own or together with the Myc-tagged
IBV SDC (Fig. 4b, third panel, lanes 1 and 3). Western blot
analysis of the same precipitates with anti-Myc antibody detected
the Myc-tagged SDC only in cells co-expressing the two proteins
(Fig. 4b, bottom panel, lane 3). These results confirm that the N-
terminal portion of the IBV S protein can also interact with eIF3f.
Measurement of the luciferase activity in cells co-transfected
with either IBV or SARS CoV S protein showed that the luciferase
activity was drastically reduced (Fig. 4c). It confirms that IBV S
protein could also inhibit translation of the reporter gene.
Co-immunoprecipitation experiments were then carried out to
test if IBV S protein could interact with the endogenous eIF3f in
IBV-infectedcells.AsshowninFig.4d,Westernblotanalysisshowed
presenceof the S and N proteins inIBV-infected cellsusing anti-IBV
S and N antibodies, respectively (top and third panels). Immuno-
precipitaion of the same lysates with anti-eIF3f antibodies and
subsequent analysis of the precipitatesbyWestern blotwith anti-IBV
S antibodies led to the detection of the S protein in IBV-infected but
not in mock-infected cells (Fig. 4d, second panel). Western blot
analysis of the same precipitates with anti-IBV N antibodies,
however, did not detect the N protein (Fig. 4d, fourth panel). These
resultsconfirmthatIBVScouldindeedinteractwiththeendogenous
eIF3f protein in virus-infected cells.
Significantly more efficient translation of proteins in
cells expressing a fusion-competent S protein than
in cells expressing a fusion incompetent S protein
Expression in cells of a fusion-competent IBV S protein (IBV
S(p65)) cloned from a Vero cell-adapted IBV passage 65 (p65) and
fusion-incompetent S protein (IBV S(EP3)) cloned from chicken
embryo passage 3 (EP3) (unpublished observation) was carried out
to support that interaction between S protein and eIF3.5 leads to
inhibition of protein translation. It was reasoned that in cells
transfected with IBV S(EP3), expression of the S protein would be
inhibited after the protein synthesis reaches to a certain level, as
the S protein already synthesized would bind to eIF3.5, leading to
the inhibition of translation and a lower level of S protein
synthesis. On the contrary, in cells transfected with IBV S(p65),
these initially transfected cells would fuse with the neighboring
cells after the S protein expression reaches to a certain level and
the eIF3.5 factor present in these neighboring cells would offset the
inhibitory effect of the S protein, resulting in a higher level of S
protein synthesis. As expected, no cell-cell fusion was observed in
cells expressing IBV S(EP3) at 6, to 12 hours post-infection
(Fig. 5a). In cells expressing IBV S(p65), small syncytial cells were
observed at 8 hours post-infection (Fig. 5a). Giant syncytial cells
were observed on almost the whole monolayer at 10 to 12 hours
post-infection (Fig. 5a). Western blot analysis showed that slightly
more S protein was observed in cells expressing S(EP3) construct
at 6 hours post-infected, compared to cells expressing S(p65)
construct (Fig. 5b, lanes 1 and 5). At 8 hours post-infection,
approximately equal amounts of S protein were detected in cells
expressing both constructs (Fig. 5b, lanes 2 and 6). Much more S
protein was detected in cells expressing S(p65) than did in cells
expressing S(EP3) at 10 and 12 hours post-infection (Fig. 5b, lanes
3, 4, 7 and 8). As a loading control, very similar amounts of the b-
tubulin were detected in samples (Fig. 5b). Analysis of the
expression of the two constructs at the mRNA level by realtime
RT-PCR showed that very similar amounts of mRNA were
detected in cells expressing the two constructs at 6–10 hours post-
transfection.
To obtain more quantitative data, the luciferase gene was fused
to the C-terminus of the S(EP3) and S(p65), respectively. A furin
cleavage site was placed between the S and luciferase sequences.
As shown in Fig. 5c, transfection of the two constructs into Vero
cells showed presence of 5 and 10 fold more luciferase activity in
cells expressing the S(p65)-luciferase fusion construct than in cells
expressing the S(EP3)-luciferase construct at 12 and 14 hours post-
transfection, respectively (Fig. 5c).
Enhanced translation of IL-6 and IL-8 in IBV-infected
cells stably expressing the Flag-tagged eIF3f
A stable cell line expressing the Flag-tagged eIF3f was then
established from Vero cells to further study the inhibitory effect of
S protein on the expression of IBV-induced genes. Several G418-
selected clones showed the expression of the Flag-tagged eIF3f
with different efficiencies. One stable cell line with high expression
and one with undetectable expression of the Flag-eIF3f were
chosen for the study (Fig. 6a). The two cell clones were infected
with IBV in a time-course experiment (Fig. 6a). Analysis of viral
RNA at 0, 8 12, 16 and 24 hours post-infection, respectively,
showed the presence of very similar amounts of viral RNAs in both
cell clones (Fig. 6b). However, significantly less S protein was
detected in cells stably expressing the Flag-tagged eIF3f at earlier
time points (Fig. 6b, lanes 3, 4, 8 and 9). Quantitative analysis of
the S protein bands by densitometry showed that 3.87-, 4.65- and
0.9-fold more S protein was detected in cells without expressing
the Flag-tagged eIF3f than that in cells expressing the Flag-tagged
eIF3f at 12, 16 and 24 hours post-infection, respectively (Fig. 6b,
lanes 3–5 and 8–10).
Analysis of IL-8 at the transcriptional level by Northern blot
showed induction of IL-8 mRNA in both cell clones infected with
IBV, but obviously more induction of IL-8 mRNA in cells without
expressing the Flag-tagged eIF-3f was detected (Fig. 6c, upper
panels). Western blot analysis of IL-8 at the translational level
showed detection of IL-8 in both cell clones (Fig. 6c, lower panels).
Interestingly, much more induction of the IL-8 protein expression
Coronavirus S and eIF3f
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time points (Fig. 6c, lower panels). Quantitative analysis by
densitometry showed that 6-, 2.58- and 0.82-fold more IL-8 was
present in cells expressing the Flag-tagged eIF3f than that in cells
without expressing the Flag-tagged eIF3f at 12, 16 and 24 hours
post-infection, respectively (Fig. 6c, lanes 3–5 and 8–10). These
results confirm that stable expression of the Flag-tagged eIF3f
could offset the inhibitory effect of S protein on the translation of
virus-inducible genes.
Similarly, analysis of IL-6 at the transcriptional level by
Northern blot showed induction of IL-6 mRNA in both cell
clones infected with IBV at 8 (Fig. 6d, lanes 1 and 5), 12 (Fig. 6d,
lanes 2 and 6), 16 (Fig. 6d, lanes 3 and 7) and 24 (Fig. 6d, lanes 4
and 8) hours post-infection, respectively. Slightly more induction
Figure 4. Interaction of the IBV S protein with eIF3f and inhibition of protein synthesis. a. Confirmation of the interaction between the Flag-
tagged eIF3f and the full-length IBV S protein by co-immunoprecipitation. HeLa cells expressing the Flag-tagged eIF3f (lane 1), IBV S (lane 2) and
eIF3f+IBV S (lane 3) by using the vaccinia/T7 expression system were harvested at 24 hours post-transfection and lysed. The total cell lysates were
either detected directly by Western blot with anti-Flag (top panel) and anti-IBV S (second panel) antibodies or immunoprecipitated with anti-IBV S
antibodies. The precipitates were analyzed by Western blot with anti-IBV S (third panel) and anti-Flag (bottom panel) antibodies. b. Interaction of the
Flag-tagged eIF3f with the N-terminal region of the IBV S protein (IBV SDC). HeLa cells expressing the Flag-tagged eIF3f (lane 1), the Myc-tagged IBV
SDC (lane 2) and eIF3f+IBV SDC (lane 3), were harvested at 24 hours post-transfection and lysed. The total cells lysates were either detected directly
by Western blot with anti-Flag (top panel) and anti-Myc (second panel) antibodies, or immunoprecipitated with anti-Flag antibody. The precipitates
were analyzed by Western blot with anti-Flag (third panel) or anti-Myc (bottom panel) antibodies. c. Inhibition of luciferase activity by IBV and SARS-
CoV S protein. HeLa cells expressing luciferase, luciferase+IBV S and luciferase+SARS-CoV S by using the vaccinia/T7 system were harvested at
24 hours post-transfection, lysed, and the luciferase activities in the total cell lysates were measured. d. Co-immunoprecipitation analysis of the
interaction between IBV S protein and the endogenous eIF3f in IBV-infected Vero cells. Mock- and IBV-infected Vero cells were harvested at 24 hours
post-infection and lysed. The total cell lysates were either detected directly by Western blot with anti-IBV S (top panel), anti-IBV N (third panel) and
anti-actin (bottom panel) antibodies, respectively, or immunoprecipitated with anti-eIF3f antibody. The precipitates were analyzed by Western blot
with anti-IBV S (second panel) or N (fourth panel) antibodies.
doi:10.1371/journal.pone.0001494.g004
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tagged eIF-3f was observed at 16 hour post-infection (Fig. 6d,
lanes 3 and 7). The expression of IL-6 at the translational level was
then analyzed by collecting the culture media and total infected
cells at 24 hours post-infection by Western blot. Drastically
increased detection (5-fold) of IL-6 in the supernatants in cells
expressing the Flag-tagged eIF3f was detected (Fig. 6d, lanes 9 and
10). Slightly enhanced expression of IL-6 was also detected in total
cell lysates (Fig. 6d, lanes 11 and 12).
DISCUSSION
Induction and over-production of proinflammatory cytokines and
chemokines, such as IL-6, IL-8, TNF-a and INF-c, were
considered to be main mediators in the pathogenesis of SARS
[5,8–9]. These cytokines and chemokines could promote inflam-
mation by induction of acute cell and tissue injury. Understanding
the cellular and viral mechanisms that regulate the induction of
these molecules at the transcriptional and translational levels
would be essential for understanding the pathogenesis of
coronavirus. In this study, the S protein of SARS-CoV and IBV
was shown to interact with the initiation factor eIF-3f, leading to
the inhibition of general protein synthesis. As the inhibition occurs
at late stages of the virus replication cycle, the main effect would
be on the translation of virus-induced transcripts, including
predominantly proinflammatory cytokines and chemokines. This
inhibition may therefore play an important role in regulation of
the pathogenesis of coronavirus.
As an illustrative example shown in this study, IBV-infection of
Vero cells induces a drastic increase of IL-6 mRNA transcription
at 8–24 hours post-infection. However, only a moderate increase
of IL-6 expression at the protein level was detected. The same
phenomena were also reported in cells infected with SARS-CoV
and in SARS patients. The IL-6 mRNA was significantly up-
regulated in SARS-CoV-infected dendritic cells [5]. However,
only slight increase of IL-6 at the protein level was detected in the
serum of SARS patients [9]. In addition, Tseng et al. [34] also
reported that IL-6 protein only increased two fold in macrophages
and dendritic cells infected SARS-CoV. These studies support that
differential regulation of host cell mRNA transcription and protein
Figure 5. The relationship between the fusogenicity of S protein and its expression level in cells expressing fusion-competent and fusion-
incompetent S protein. a. Detection of cell-cell fusion by indirect immunofluorescence. Vero cells were infected with the vaccinia/T7 recombinant
virus and transfected with S(EP3) and S(p65) constructs. At 6, 8, 10 and 12 hours post-transfecion, respectively, cells were fixed with 4%
paraformaldehyde and stained with rabbit anti-IBV S polyclonal antibodies. b. Expression of fusion-competent and fusion-incompetent IBV S protein.
Vero cells were infected with vaccinia/T7 recombinant virus and transfected with S(EP3) and S(p65) constructs. Cells were harvested at 6, 8, 10 and
12 hours post-transfection, respectively, and lysates prepared. The viral protein expression was analyzed by Western blot with rabbit anti-IBV S
antibodies. The same membrane was also probed with anti-b-tubulin monoclonal antibody as a loading control. c. Quantitative analysis of the
expression of fusion-competent and fusion-incompetent IBV S protein. Vero cells were infected with vaccinia/T7 recombinant virus and transfected
with S(EP3)-luciferase and S(p65)-luciferase constructs. Cells were harvested at 12 and 14 hours post-transfection, respectively, lysates prepared, and
the luciferase activity was determined.
doi:10.1371/journal.pone.0001494.g005
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on translation rendered by the interaction between coronavirus S
protein and eIF3f may account for the observed differential
induction of virus-inducible genes at the transcriptional and
translational levels.
Is the observed inhibition of translation by the interaction of
coronavirus S protein with eIF3f beneficial to the virus? The
inhibitory effect appears to be general, as the synthesis of both viral
and cellular proteins can be affected. However, as accumulation of
the S protein to a certain level in the virus-infected cells is a
prerequisite for the inhibition, it would be effective only at late
stages of viral infection. This would be largely beneficial to the
virus. At this stage, the viral RNA replication and protein synthesis
in a given infected cell are nearly complete, inhibition of viral
protein synthesis would render little effect on viral production and
subsequent infection of neighboring cells. On the contrary,
inhibition of host protein synthesis, especially the translation of
virus-induced transcripts which are accumulated at very high
concentration at this stage, would dramatically reduce the
production of protein products from these genes. As most of these
products are proinflammatory cytokines and chemokines, synthesis
and secretion of these products would cause inflammatory
response, sensitize the neighboring cells as well as causing cell
death. The most direct consequence of these cell/tissue responses
Figure 6. Analysis of IL-6 and IL-8 expression at mRNA and protein levels in IBV-infected cells stably expressing the Flag-tagged eIF-3f. a. IBV
infection of Vero cell clones stably expressing of the Flag-tagged eIF3f. Two stable Vero cell clones with high level expression of the Flag-tagged eIF3f
(lanes 2, 4, 6, 8 and 10) and undetectable expression of the Flag-tagged eIF3f (lanes 1, 3, 5, 7 and 9), respectively, were infected with IBV at a multiplicity
of infection of 2 and harvested at 0, 8, 12, 16 and 24 hours post-infection. The expression of the Flag-tagged eIF3f was analyzed by Western blot with
anti-Flag antibody. Thesame membranewas also probedwith anti-actinantibodiesas a loadingcontrol.b. Analysis of viral RNA replication andprotein
synthesis in IBV-infected stable cells clones with high expression of eIF3f (+eIF3f) (lanes 1–5) and undetectable expression of eIF3f (-eIF3f) (lanes 6–10).
The two stable Vero cell clones were infected with IBV at a multiplicity of infection of 2 and harvested at 0, 8, 12, 16 and 24 hours post-infection. Ten
micrograms of total RNA extracted from one portion of the harvested infected cells were separated on 1.3% agarose gel and transferred to a Hybond
N+ membrane. Viral RNAs were probed with a Dig-labeled DNA probe corresponding to the 39 end 680 nucleotides of the IBV genome. Bands
corresponding to the genomic and subgenomic mRNA are indicated by numbers 1–6 on the right. The same membrane was also probed with a Dig-
labeled GAPDH probe as loading control. The viral protein expression was analyzed by Western blot of total cell lysates prepared from another portion
of the harvested infected cells with anti-IBV S protein antibodies. The same membrane was also analyzed by Western blot with anti-actin antibodies. c.
Analysis of IL-8 expression. The total RNA preparations were analyzed by Northern blot with a Dig-labelled IL-8 probe (upper panels). The IL-8
expression at the protein level was analyzed by Western blot analysis with anti-IL-8 antibodies (lower panels). d. Analysis of IL-6 expression. The total
RNA preparations were analyzed by Northern blot with a Dig-labelled IL-6 probe (lanes 1–8). The IL-6 expression at the protein level was analyzed by
Western blot analysis of culture media (lanes 9 and 10) and total cell lysates (lanes 11–12) harvested 24 h post-infection with anti-IL-6 antibodies.
Western blot analysis of the total cell lysates with anti-actin antibodies was included as a loading control (lanes 11 and 12).
doi:10.1371/journal.pone.0001494.g006
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study therefore reveals a novel viral mechanism that controls the
cellular anti-viral response. In fact, infection of cells stably
expressing the Flag-tagged eIF3f with IBV showed reduced virus
production, compared with cells without expression of the protein.
It supports that inhibition of the translation of virus-induced
transcripts is beneficial to the virus. At present, we could not rule
out the possibility that stable expression of the Flag-tagged eIF3f
may affect the general translation of host cells, although the cells
appear to be normal.
Attempts to map the interaction region in the S protein in more
details by co-immunoprecipitation and yeast two-hybrid system
were unsuccessful, due to the presence of multiple interaction sites.
Sequence comparison between the SARS-CoV S protein and the
IBV S protein showed low homology (26.1% amino acid identity).
However, regions with high similarity in the amino acid sequences
between the two S proteins were found. For example, the region
from amino acids 207–264 of the IBV S protein shares 58.62%
amino acid similarity with the region from amino acids 264–321 in
the SARS-CoV S protein. Alternatively, the interaction would be
mediated by the carbohydrate chain of the S protein. However, as
no other glycoproteins of coronavirus were found to be interacted
with eIF3f, there is no evidence to support this speculation at
present.
Where is the precise cellular site for this interaction?
Coronavirus S protein is a type I membrane protein. The N-
terminal part of the protein is normally not exposed to the
cytoplasmic side of the membranous compartments of the cell. On
the other hand, eIF3f is presumably a protein located mainly in the
cytosol and nucleus [35–36]. This would prevent or at least reduce
the contact between the two proteins. However, immunofluores-
cent staining of cells expressing the two proteins clearly showed
that the SARS-CoV S protein could interact with eIF3f and
sequester the later to the site of S protein. It is likely that eIF3f
could gain access to the luminal side of the membranous
compartments and interact with the S protein. An alternative
explanation may lie on the fact that multiple N-terminally
truncated forms of the S protein can be detected in cells either
infected with SARS-CoV and IBV or transfected with S protein
constructs from both viruses (data not shown). As no transmem-
brane domain in this region, these N-terminally truncated S
species may be localized mainly in the cytoplasm and interact with
eIF3f.
Cell-cell fusion can be induced in cells either infected with most
coronaviruses or transfected with the S protein construct.
Interestingly, it was consistently observed that a higher level of S
protein expression was detected in cells expressing fusion-
competent IBV S protein constructs than that in cells expressing
fusion incompetent IBV S protein (data not shown). Similar
observations were also reported in studies of other coronavirus S
proteins [37–39]. Fusion of the neighboring cells would provide
additional fresh eIF3f, which in turn enhances the expression of
virus-induced transcripts pre-existed in the originally infected cells.
It is therefore likely that inhibition of S protein-mediated fusion
may, in addition to the inhibition of virus entry, alleviate the
production of pathological cytokines and chemokines, leading to
the reduction of cell damage caused by these products during the
course of coronavirus infection. This would open a new area for
design of anti-viral therapeutics.
ACKNOWLEDGMENTS
We would like to thank Y. C. Law for technical assistance.
Author Contributions
Conceived and designed the experiments: DL. Performed the experiments:
HX LX YY. Analyzed the data: DL HX LX YY. Wrote the paper: DL
HX.
REFERENCES
1. Cebulla CM, Miller DM, Sedmak DD (1999) Viral inhibition of interferon signal
transduction. Intervirology 42: 325–330.
2. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. (2002) Induction of
proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses:
a mechanism for the unusual severity of human disease? Lancet 360: 1831–1837.
3. Guidotti LG, Chisari FV (2000) Cytokine-mediated control of viral infections.
Virology 273: 221–227.
4. Jones BM, Ma ES, Peiris JS, Wong PC, Ho JC, et al. (2004) Prolonged
disturbances of in vitro cytokine production in patients with severe acute
respiratory syndrome (SARS) treated with ribavirin and steroids. Clin Exp
Immunol 135: 467–473.
5. Law HKW, Cheung CY, Ng HY, Sia SF, Chan YO, et al. (2005) Chemokine
up-regulation in SARS-coronavirus–infected, monocyte-derived human den-
dritic cells. Immunobiology. 106: 2366–2374.
6. Yu LM, Hui DS, Tam JS, Cheng G, Sung JJ (2003) Haematological
manifestations in patients with severe acute respiratory syndrome: retrospective
analysis. British Medical Journal 326: 1358–1362.
7. Glass WG, Subbarao K, Murphy B, Murphy PM (2004) Mechanisms of host
defense following severe acute respiratory syndrome-coronavirus (SARS-CoV)
pulmonary infection of mice. J Immunol 173: 4030–4039.
8. Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, et al. (2004) Plasma
inflammatory cytokines and chemokines in severe acute respiratory syndrome.
Clin Exp Immunol 136: 95–103.
9. Zhang YC, Li J, Zhan YL, Wu LQ, Yu X, et al. (2004) Analysis of Serum
Cytokines in Patients with Severe Acute Respiratory Syndrome. Infection and
Immunity 72: 4410–4415.
10. Ziegler T, Sampsa M, Esa R, Pamela O, Maarit S, et al. (2005) Severe acute
respiratory syndrome coronavirus fails to activate cytokine-mediated innate
immune responses in cultured human monocyte-derived dendritic cells. J Virol
79: 13800–13805.
11. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, et al. (2003) Coronavirus as a
possible cause of severe acute respiratory syndrome. Lancet 361: 1319–1325.
12. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, et al. (2003)
Characterization of a novel coronavirus associated with severe acute respiratory
syndrome. Science 300: 1394–1399.
13. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, et al. (2003) The
genome sequence of the SARS-associated coronavirus. Science 300: 1399–1404.
14. Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, et al. (2003) Unique
and Conserved features of genome and proteome of SARS-coronavirus, an early
split-off from the coronavirus group 2 lineage. J Mol Biol 331: 991–1004.
15. Thiel V, Ivanov KA, Putics A, Hertzig T, Schelle B, et al. (2003) Mechanisms
and enzymes involved in SARS coronavirus genome expression. J Gen Virol 84:
2305–2315.
16. Silverman RH, Williams BRG (1999) Translational control perks up. Nature
397: 208–211.
17. Ahmed M, McKenzie MO, Puckett S, Hojnacki M, Poliquin L, et al. (2003)
Ability of the matrix protein of vesicular stomatitis virus to suppress beta
interferon gene expression is genetically correlated with the inhibition of host
RNA and protein synthesis. J Virol 77: 4646–4657.
18. Black BL, Lyles DS (1992) Vesicular stomatitis virus matrix protein inhibits host
cell-directed transcription of target genes in vivo. J Virol 66: 4058–4064.
19. Ferran MC, Lucas-Lenard JM (1997) The vesicular stomatitis virus matrix
protein inhibits transcription from the human beta interferon promoter. J Virol
71: 371–377.
20. Yuan H, Yoza BK, Lyles DS (1998) Inhibition of host RNA polymerase II-
dependent transcription by vesicular stomatitis virus results from inactivation of
TFIID. Virology 251: 383–392.
21. Schneider RJ (2000) Cold Spring Harbor Laboratory Press. In: Hershey JWB,
et al. eds. Translational Regulation. Adenovirus inhibition of cellular protein
synthesis and preferential translation of viral mRNAs. pp 901–914.
22. Laurent AM, Madjar JJ, Greco A (1998) Translational control of viral and host
proteinsynthesisduringthe course ofherpessimplex virus type 1 infection: evidence
that initiation of translation is the limiting step. J Gen Virol 79: 2765–2775.
23. Schneider RJ, Mohr I (2003) Translation initiation and viral tricks. Trends in
Biochemical Sciences 28: 130–136.
24. Alcami A, Koszinowski UH (2000) Viral mechanisms of immune evasion.
Immunol Today 21: 447–455.
25. Ali IK, McKendrick L, Morley SJ, Jackson RJ (2001) Truncated initiation factor
eIF4G lacking an eIF4E binding site can support capped mRNA translation.
EMBO J 20: 4233–4242.
Coronavirus S and eIF3f
PLoS ONE | www.plosone.org 10 January 2008 | Issue 1 | e149426. Gale MJ, Tan SL, Katze MG (2000) Translational control of viral gene
expression in eukaryotes. Microbiol. Mol Biol Rev 64: 239–280.
27. Joachims M, Van-Breugel PC, Lloyd RE (1999) Cleavage of poly(A)-binding
protein by enterovirus proteases concurrent with inhibition of translation in
vitro. J Virol 73: 718–727.
28. Lamphear B, Yan R, Yang F, Waters D, Liebig HD, et al. (1993) Mapping the
cleavage site in protein synthesis initiation factor eIF-4g of the 2A proteases from
human Coxsackievirus and rhinovirus. J Biol Chem 268: 19200–19203.
29. Katsura A, Kinzy TG, Merrick WC, Hershey JWB (1997) Conservation and
Diversity of Eukaryotic Translation Initiation Factor eIF3. J Biol Chem 272:
1101–1109.
30. Keith RJ, Merrick WC, Zoll WL, Zhu Y (1997) Identification of cDNA Clones
for the Large Subunit of Eukaryotic Translation Initiation Factor 3. Comparison
of homologues from human, nicotiana tabacum, caenorhabditis elegans, and
saccharomyces cerevisiae. J Biol Chem 272: 7106–7113.
31. Nathalie M, Rom E, Olsen H, Sonenberg N (1997) The Human Homologue of
the Yeast Prt1 Protein Is an Integral Part of the Eukaryotic Initiation Factor 3
Complex and Interacts with p170. J Biol Chem 272: 1110–1116.
32. Wang L, Tam JP, Liu DX (2006) Biochemical and functional characterization of
Epstein-Barr Virus-encoded BARF1 protein: interaction with human hTid1
protein facilitates its maturation and secretion. Oncogene 25: 4320–4331.
33. Liu DX, Xu HY, Brown TDK (1997) Proteolytic processing of the coronavirus
infectious bronchitis virus 1a polyprotein: Identification of a 10 kDa polypeptide
and determination of its cleavage sites. J Virol 71: 1814–1820.
34. Tseng CT, Perrone LA, Zhu H, Makino S, Peters CJ (2005) Severe acute
respiratory syndrome and the innate immune responses: modulation of effector
cell function without productive infection. J Immunol 174: 7977–7985.
35. Shi J, Kahle A, Hershey JW, Honchak BM, Warneke JA, et al. (2006) Decreased
expression of eukaryotic initiation factor 3f deregulates translation and apoptosis
in tumor cells. Oncogene 25: 4923–4936.
36. Shi J, Feng Y, Goulet AC, Vaillancourt RR, Sachs NA, et al. (2003) The
p34cdc2-related cyclin-dependent kinase 11 interacts with the p47 subunit of
eukaryotic initiation factor 3 during apoptosis. J. Biol. Chem. 278: 5062–71.
37. Bos EC, Heijnen L, Luytjes W, Spaan WJ (1995) Mutational analysis of the
murine coronavirus spike protein: effect on cell-to-cell fusion. Virology 214:
453–463.
38. Bosch BJ, van der Zee R, de Haan CAM, Rottier PJM (2003) The coronavirus
spike protein is a class I virus fusion protein: structural and functional
characterization of the fusion core complex. J Virol 77: 8801–8811.
39. de Haan CAM, Stadler K, Godeke GJ, Bosch BJ, Rottier PJM (2004) Cleavage
inhibition of the murine coronavirus spike protein by a furin-like enzyme affects
cell-cell but not virus-cell fusion. J Virol 78: 6048–6054.
Coronavirus S and eIF3f
PLoS ONE | www.plosone.org 11 January 2008 | Issue 1 | e1494